actavis.nl Report : Visit Site

Technical data of the actavis.nl

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host actavis.nl. Currently, hosted in Israel and its service provider is TEVA .

the related websites

chemistanddruggist.co.uk medicines.org.uk gov.uk thesun.co.uk ilacrehberi.com menspharmacy.co.uk supremecourt.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

-- pharmaceutical industries ltd. teva worldwide stock your browser does not support iframes. contact us hebrew see teva's sites around the world north america canada united states international markets argentina australia belarus brazil chile china india israel japan kazakhstan mexico peru russia singapore south africa south korea turkey ukraine uruguay uzbekistan europe europe austria belgium bosnia & herzegovina bulgaria croatia czech republic denmark estonia finland france germany greece hungary iceland ireland italy latvia lithuania macedonia netherlands norway poland portugal romania serbia slovakia slovenia spain sweden switzerland united kingdom see all see less want to find out more about teva's locations and phone numbers? visit teva worldwide a race against time discover more finding the balance discover more about about lobby company profile corporate officers corporate governance our history 2018 annual report – form 10-k quality products products lobby specialty generic products generic faq over the counter (otc) api quality central nervous system (cns) respiratory research research lobby our philosophy patient promise pipeline clinical trials teva specialty pipeline responsibility responsibility lobby social impact positions & policies patient advocacy social impact report multiple chronic conditions media media lobby latest news featured stories social media featured stories social media investors investors lobby press releases events & presentations financial information debt information stock information corporate governance investor resources careers careers lobby dare to be different our guiding values leadership development working at teva dare to be different search teva jobs teva worldwide stock contact us hebrew follow us: teva in action see what we’re doing and where all news top news mar 22, 2019 teva announces launch of a generic version of exjade® (deferasirox) tablets for oral suspension in the united states learn more share top news mar 1, 2019 teva announces launch of an authorized generic of flector® patch (diclofenac epolamine topical patch) in the united states learn more share top news feb 19, 2019 teva finalizes settlement with federal trade commission to resolve all outstanding litigation between the parties learn more share top news feb 13, 2019 teva reports fourth quarter and full year 2018 financial results learn more share top news feb 6, 2019 teva announces u.s. launch of a generic version of sabril® (vigabatrin) learn more share tour our state-of-the-art ulm biopharm facility featured stories take a closer look at what’s happening at teva all featured stories #balanceforbetter sara zavaleta discover more #balanceforbetter: merav bassan discover more battling multiple chronic conditions together #balanceforbetter jeannette brend discover more #balanceforbetter maša rajic linaric discover more leading a responsible business our unique perspective on health enables you to live better days specialized in cns & respiratory cutting-edge r&d uncompromising quality the world’s generic leader corporate responsibility this site uses cookies to give you a better browsing experience. by continuing to use this website, you accept our use of these cookies. for more information, see our privacy and cookie notice . about company profile corporate officers corporate governance our history products specialty generic products generic faq over the counter (otc) api quality research our philosophy patient promise pipeline clinical trials responsibility social impact positions & policies patient advocacy media latest news featured stories social media investors press releases events & presentations financial information debt information stock information corporate governance investor resources careers dare to be different our guiding values leadership development working at teva follow teva: legal notes data privacy phv privacy notice tapi teva supplier code of conduct sitemap supplier faq's © 2018

URL analysis for actavis.nl

https://www.tevapharm.com/teva_worldwide/international_markets/teva_in_israel/
https://www.tevapharm.com/teva_worldwide/north_america/usa/
https://www.tevapharm.com/teva_careers/career_value/
https://www.tevapharm.com/research_development/patient_safety/
https://www.tevapharm.com/research_development/
https://www.tevapharm.com/about/corporate_governance/
http://www.facebook.com/sharer.php?u=https://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2018_financial_results_02_19.aspx
https://www.tevapharm.com/featuredstories/
https://www.tevapharm.com/news/
https://www.tevapharm.com/our_products/specialty_products/cns/
https://www.tevapharm.com/corporate_responsibility/social_impact/social_impact_report/
https://www.tevapharm.com/?catid=%7b02fc8e41-7f0f-4c1c-bf25-aaf3ef13818e%7d
https://twitter.com/share?url=https://www.tevapharm.com/news/teva_announces_u_s_launch_of_a_generic_version_of_sabril_vigabatrin_02_19.aspx
https://www.tevapharm.com/?catid=%7b88a913d4-8a0b-4e8f-88d4-1682e3b89f4a%7d
https://www.tevapharm.com/?catid=%7b2cff3f80-1926-4625-bccd-dc5f278bad3f%7d

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name: actavis.nl
Status: active

Registrar:
Com Laude
28-30 Little Russell Street
2nd floor
WC1A2HN London
United Kingdom of Great Britain & N Ireland

Abuse Contact:

DNSSEC: no

Domain nameservers:
ns3.tevapharm.com
ns4.tevapharm.com
ns5.tevapharm.com

Record maintained by: NL Domain Registry

As the registrant's address is not in the Netherlands, the registrant is
obliged by the General Terms and Conditions for .nl Registrants to use
SIDN's registered office address as a domicile address. More information
on the use of a domicile address may be found at
https://www.sidn.nl/downloads/procedures/Domicile_address.pdf


Copyright notice
No part of this publication may be reproduced, published, stored in a
retrieval system, or transmitted, in any form or by any means,
electronic, mechanical, recording, or otherwise, without prior
permission of the Foundation for Internet Domain Registration in the
Netherlands (SIDN).
These restrictions apply equally to registrars, except in that
reproductions and publications are permitted insofar as they are
reasonable, necessary and solely in the context of the registration
activities referred to in the General Terms and Conditions for .nl
Registrars.
Any use of this material for advertising, targeting commercial offers or
similar activities is explicitly forbidden and liable to result in legal
action. Anyone who is aware or suspects that such activities are taking
place is asked to inform the Foundation for Internet Domain Registration
in the Netherlands.
(c) The Foundation for Internet Domain Registration in the Netherlands
(SIDN) Dutch Copyright Act, protection of authors' rights (Section 10,
subsection 1, clause 1).

  REFERRER http://www.domain-registry.nl

  REGISTRAR Stichting Internet Domeinregistratie NL

SERVERS

  SERVER whois.domain-registry.nl

  ARGS actavis.nl

  PORT 43

  TYPE domain

DOMAIN

  NAME actavis.nl

  STATUS active

SPONSOR
Com Laude
28-30 Little Russell Street
2nd floor
WC1A2HN London
United Kingdom of Great Britain & N Ireland
Abuse Contact:
DNSSEC: no

NSERVER

  NS3.TEVAPHARM.COM 199.7.68.228

  NS4.TEVAPHARM.COM 199.7.69.228

  NS5.TEVAPHARM.COM 204.74.114.228

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .